US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.190
  • -0.010-0.45%
Close Jan 3 16:00 ET
  • 2.190
  • +0.000+0.01%
Post 19:50 ET
431.51MMarket Cap-3.27P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Esperion Therapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
51.71M
51.63M
-81.62K
Miss Est.
+52.24%
+52.00%
-0.16%
EPS
-0.18
-0.15
+0.03
Beat Est.
+52.64%
+59.46%
+14.38%
Analyst Rating
Buy

Dec 31, 2024

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.303M--
--2024/Q4-- / 62.141M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.303M--
--2024/Q4-- / 62.141M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--

Unlock Free Earnings Estimates

Esperion Therapeutics Earnings Reports

  • Esperion Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:29 ET

  • Esperion Therapeutics | 8-K: Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update

    Nov 7, 2024 07:23 ET

  • Esperion Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 16:12 ET

  • Esperion Therapeutics | 8-K: Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 12, 2024 07:26 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DexCom
    DXCM
    +3.27%
    Collegium Pharmaceutical
    COLL
    +3.07%
    Lantheus
    LNTH
    +2.71%
    Cars.com
    CARS
    +1.72%
    YETI Holdings
    YETI
    +1.60%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      71.43%

    • Hold

      14.29%

    • Sell

      14.29%

    Price Target

    No Data